Method and system for reducing the likelihood of a spirochetes infection in a human being
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/00
A61K-035/74
A61K-031/4704
A61K-031/65
A61K-031/519
A61C-019/06
A61K-039/00
A61K-045/06
A61K-035/741
A61K-035/742
A61K-035/745
A61K-035/747
출원번호
US-0342642
(2016-11-03)
등록번호
US-10010568
(2018-07-03)
발명자
/ 주소
Kovarik, Katherine Rose
Kovarik, Joseph E.
출원인 / 주소
Kovarik, Katherine Rose
대리인 / 주소
Sheridan Ross P.C.
인용정보
피인용 횟수 :
0인용 특허 :
33
초록▼
A method and system of reducing the likelihood of an inflammatory disease developing by providing a mucosal adhesive strip to a subject, with the strip provided with at least one of a plurality of agents effective to hinder the growth of spirochetes bacteria in a subject's oral cavity. In certain em
A method and system of reducing the likelihood of an inflammatory disease developing by providing a mucosal adhesive strip to a subject, with the strip provided with at least one of a plurality of agents effective to hinder the growth of spirochetes bacteria in a subject's oral cavity. In certain embodiments, an effective amount of Prevotella intermedia is provided to decrease the incidence of periodontitis and to reduce the progression of Alzheimer's disease. In still other embodiments, the likelihood that a subject will suffer from Alzheimer's disease is reduced by administering via local gingival application to a subject that has been diagnosed with periodontitis an effective amount of an antibiotic effective to kill spirochetes bacteria residing on the subgingival tooth area of the subject.
대표청구항▼
1. A method of reducing the likelihood of a Treponema spirochete infection in a human being, comprising, providing a bioadhesive strip to a human being who has been diagnosed with periodontitis, said strip adapted to bind to a mucosal membrane of said human being, the strip having a first and second
1. A method of reducing the likelihood of a Treponema spirochete infection in a human being, comprising, providing a bioadhesive strip to a human being who has been diagnosed with periodontitis, said strip adapted to bind to a mucosal membrane of said human being, the strip having a first and second side, the first side having a bioadhesive that is adapted to bind to a mucosal membrane for at least 1 hour while inside a person's mouth, wherein said strip comprises a polymer, and between 0.2 and 0.9% xylitol by weight, and a therapeutically effective amount of an anti-biofilm agent, and an antibiotic comprising at least one of methotrexate and paquinimod, in an amount effective to inhibit collagenase activity. 2. The method as set forth in claim 1, further comprising orally administering to the subgingival tooth area of the human being a second antibiotic in an effective amount to kill Treponema spirochetes bacteria residing on the subgingival tooth area of the human being wherein said antibiotic comprises one of azithromycin and ceftriaxone. 3. The method as set forth in claim 1, wherein said strip comprises bioluminescent material. 4. The method as set forth in claim 1, wherein said strip comprises compounds that facilitate the growth of desired bacteria beneficial to a person's health. 5. A method of reducing the likelihood of a Treponema spirochete infection in a human being, comprising, providing a bioadhesive strip to a human being who has been diagnosed with periodontitis, wherein said strip has a first and second side, the first side having a bioadhesive that is adapted to bind to a mucosal membrane for at least 3 hours while inside a person's mouth, said strip being devoid of manganese and copper, wherein said strip includes at least about 200 mg xylitol and an effective amount of paquinimod to inhibit collagenase activity. 6. The method as set forth in claim 5, further comprising orally administering to the subgingival tooth area of the human being a second antibiotic in an effective amount to kill Treponema spirochetes bacteria residing on the subgingival tooth area of the human being, wherein said antibiotic comprises one of methotrexate, azithromycin and ceftriaxone. 7. The method as set forth in claim 5, wherein said strip includes between 0.2 and 0.9% xylitol by weight. 8. The method as set forth in claim 5, wherein said strip comprises bioluminescent material. 9. The method as set forth in claim 5, wherein said strip has a surface topography for resisting bioadhesion and a pattern defined by a plurality of spaced apart features attached to or projected into a base surface, said plurality of features each having at least one microscale dimension and having at least one neighboring feature having a substantially different geometry, wherein an average spacing between adjacent ones of said features is between 0.5 and 5 microns. 10. A method of reducing the likelihood of a Treponema spirochete infection in a human being, comprising, providing a bioadhesive strip to a human being who has been diagnosed with periodontitis, wherein said strip has a first and second side, the first side having a bioadhesive that is adapted to bind to a mucosal membrane for at least 3 hours while inside a person's mouth, said strip being devoid of manganese and copper, wherein said strip includes at least about 200 mg xylitol and an effective amount of an antibiotic effective to kill spirochetes bacteria residing on the subgingival tooth area of the human being, wherein said antibiotic is selected from the group consisting of methotrexate, azithromycin and ceftriaxone. 11. The method as set forth in claim 10, wherein said strip has a surface topography for resisting bioadhesion and a pattern defined by a plurality of spaced apart features attached to or projected into a base surface, said plurality of features each having at least one microscale dimension and having at least one neighboring feature having a substantially different geometry, wherein an average spacing between adjacent ones of said features is between 0.5 and 5 microns.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (33)
Park, Yong Ha; Lee, In-seon; Kim, Hong-ik; Kang, Kook-hee, Acid tolerant .
McKenzie, Gregory; McKenzie, Mary-Jane Lombardo; Cook, David N.; Vulic, Marin; von Maltzahn, Geoffrey; Goodman, Brian; Aunins, John Grant; Henn, Matthew R.; Berry, David Arthur; Winkler, Jonathan, Compositions and methods.
Whitlock, David R., Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same.
Smith, Gary Francis; Cha, Alice Shen; Zheng, Zuoxing; Roman, Michael Gerard; Dias, Benjamin Emanuel, Dairy composition with probiotics and anti-microbial system.
Mills, David A.; Lebrilla, Carlito B.; LoCascio, Riccardo; Ninonuevo, Milady; German, J. Bruce; Freeman, Samara, Human milk oligosaccharides to promote growth of beneficial gut bacteria.
Spilburg Curtis A. (Chesterfield MO) Moore William M. (St. Charles MO), Method of inhibiting vertebrate collagenase activity using peptide hydroxamic acid derivatives.
Mittelmark, Martin; Wolverton, Billy C., Micro-irrigation device, system, and method for plant-based cleaning of indoor air and filter bed bioregeneration.
Henn, Matthew R.; von Maltzahn, Geoffrey; D'Onofrio, Anthony Mario; Litcofsky, Kevin Daniel; Berry, David A.; Cook, David N.; Afeyan, Noubar B.; Aunins, John Grant, Synergistic bacterial compositions and methods of production and use thereof.
Kerker,William S.; Paasche,Thomas D.; Bamborough,Dave; Bancino,Randy S.; Horder Koop,Robin; McDonald,Kenneth J.; Parker,John P.; Zevalkink,Claire E., System and method for managing recurring orders in a computer network.
Rajaiah, Jayanth; Ernst, Lisa Catron; Case, Ann Maria; Ha, Thinh Nguyen; Glandorf, William Michael; Mayer, Christopher Robert, Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.